Childhood Immunization Status: IPV/OPV - 3 Reproductive Health(RH) and Pediatrics
Childhood Immunization Status: MMR - 1 Reproductive Health(RH) and Pediatrics
Childhood immunization status: Dtap/DT - 4 Reproductive Health(RH) and Pediatrics
Childhood immunization status: Hep B - 3 Reproductive Health(RH) and Pediatrics
Childhood immunization status: HiB - 3 Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 1/ First dose of hepatitis B vaccine to newborn Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 10/ Second dose of Varicella zoster vaccine Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 11/ First dose of DTaP Vaccine Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 12/ Second dose of DTaP Vaccine Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 13/ Third dose of DTaP Vaccine Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 14/ Fourth dose of DTaP Vaccine Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 15/ Assessment of childhood immunization status of DTaP Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 16/ Final dose of DTaP vaccine Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 17/ First dose of inactivated poliovirus vaccine (IPV). Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 18/ Second dose of inactivated poliovirus vaccine (IPV). Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 19/ Third dose of inactivated poliovirus vaccine (IPV). Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 2/ Second dose of hepatitis B vaccine to infant Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 20/ Assessment of childhood immunization status of IPV Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 21/ Final dose of inactivated poliovirus vaccine (IPV). Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 22/ First dose of haemophilis influenza B (Hib) Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 23/ Second dose of haemophilis influenza B (Hib) Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 24/ Third dose of haemophilis influenza B (Hib Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 25/ Assessment of childhood immunization status of Hib vaccine Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 26/ First dose of Pneumococcal conjugate vaccine (PCV) Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 27/ Second dose of Pneumococcal conjugate vaccine (PCV) Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 28/ Third dose of Pneumococcal conjugate vaccine Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 29/ Fourth dose of Pneumococcal conjugate vaccine (PCV) Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 3/ Third dose of hepatitis B vaccine to infant Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 4/ Assessment of childhood immunization status for Hepatitis B Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 5/ First dose of Measles, mumps, and rubella vaccine (MMR) Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 6/ Second dose of MMR vaccine Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 7/ Assessment of childhood immunization status for MMR vaccine Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 8/ First dose of Varicella zoster vaccine Reproductive Health(RH) and Pediatrics
HEDIS Childhood Immunization Status (CIS) 9/ Assessment of childhood immunization status of VZV vaccine Reproductive Health(RH) and Pediatrics
WELL-CHILD VISITS
EPSDT Family history of children at initial well baby e-am RH and Pediatrics
EPSDT Medical history of infants at initial well baby e-am RH and Pediatrics
EPSDT Urinalysis at well baby e-am at 1 month Mental Health
ATTENTION DEFICIT HYPERACTIVITY DISORDER
Attention deficit hyperactivity syndrome - Follow up - Initial phase Mental Health
Follow up of continuation phase of attention deficit hyperactivity syndrome Mental Health
HEDIS Follow-Up Care for Children Prescribed ADHD Medication (ADD) 1/ Treatment Phases Mental Health
HEDIS Follow-Up Care for Children Prescribed ADHD Medication (ADD) 2/ Follow up in Initial Treatment Phase Mental Health
HEDIS Follow-Up Care for Children Prescribed ADHD Medication (ADD) 3/ Continuation and Maintenance (C&M) Phase Mental Health
CHILD AND ADOLESCENT PREVENTIVE SERVICES
Child > 2 yr - Screening - Height / Weight RH and Pediatrics
Child - Screening - BP Monitoring RH and Pediatrics
Child - Screening - Dental E-amination RH and Pediatrics
Child - Screening - Head Circumference RH and Pediatrics
Child - Screening - Hearing RH and Pediatrics
Child - Screening - Height/Weight RH and Pediatrics
Child - Screening - Hemoglobin RH and Pediatrics
Child - Screening - Lipid Profile RH and Pediatrics
Child - Screening - Urine Complete RH and Pediatrics
Child - Screening - Vision RH and Pediatrics
EPSDT Anemia screening in infants RH and Pediatrics
EPSDT Annual Blood pressure recording in a Child RH and Pediatrics
EPSDT Annual Dental e-amination in a child > 3 yr RH and Pediatrics
EPSDT Annual Vision testing in children > 3 years RH and Pediatrics
EPSDT Annual hearing testing in children 3-6 years RH and Pediatrics
EPSDT Autism screening in children at 18 months RH and Pediatrics
EPSDT Autism screening in children at 24 months RH and Pediatrics
EPSDT Cholesterol screening in adolescent RH and Pediatrics
EPSDT Dental e-amination in a child <> 5 years RH and Pediatrics
EPSDT Hearing testing in children 6 - 12 years RH and Pediatrics
EPSDT Hemoglobin less than 10 gm/dl in infants Unassigned Rules
EPSDT Lead screening Unassigned Rules
EPSDT Sickle cell screening in infants of African - American origin Unassigned Rules
EPSDT Tuberculosis screening in a child Unassigned Rules
EPSDT Urinalysis at 2 -12 year Unassigned Rules
EPSDT Urinalysis at 2 -6 month Unassigned Rules
EPSDT Urinalysis at 6 -18 month Unassigned Rules
EPSDT Urinalysis at well baby e-am at 1 Unassigned Rules
EPSDT hearing assessment in a child < 3 yr Unassigned Rules
EPSDT vision e-amination in a child < 3 yr Unassigned Rules
HEDIS Cervical Cancer Screening (CCS) Unassigned Rules
PEAD. AG. 2. Weight Measurement Unassigned Rules
PEAD. AG. 4. Education Unassigned Rules
Child - Screening - Dental E-amination Unassigned Rules
Neonate - Screening -Phenylketonuria Unassigned Rules
Neonate - Screening - Thyroid Func Abnormalities Unassigned Rules
Screen all individuals aged 13 - 64 years for HIV Unassigned Rules
CHILDHOOD DIABETES CARE
Diabetes (Type 1) - Inv - Lipid Profile in Prepubertal Child Unassigned Rules/page5-6
E-cess growth in babies as a complication of gestational diabetes Unassigned Rules/page5-6
Diabetes(Type 1) - Evaluaion of Growth Unassigned Rules/page5-6
Fasting lipid profile - Children - Diabetes Mellitus Unassigned Rules/page5-6
Fasting lipid profile - Diabetes Mellitus - Child - Followup Unassigned Rules/page5-6
Fasting lipid profile - Diabetes Mellitus - Pre-pubertal Children - No family history Unassigned Rules/page5-6
Fasting lipid profile - Diabetes Mellitus - Pubertal children - Follow-up Unassigned Rules/page5-6
UPPER RESPIRATORY INFECTION / PHARYNGITIS
HEDIS Appropriate Testing for Children with Pharyngitis (CWP) 1/ Investigations Custom Rules Catalog/HEDIS
HEDIS Appropriate Testing for Children with Pharyngitis (CWP) 2/ Treatment Custom Rules Catalog/HEDIS
HEDIS Appropriate Treatment for Children with Upper Respiratory Infection (URI Custom Rules Catalog/HEDIS
OTITIS MEDIA
OME: 1. Diagnostic Evaluation - Assessment of Tympanic Membrane Mobility Otolaryngology
OME: 2. Hearing Testing Otolaryngology
OME: 3. Antihistamines or Decongestants - Avoidance of Inappropriate Use Otolaryngology
OME: 4. Systemic Antimicrobials - Avoidance of Inappropriate Use Otolaryngology
OTITIS E-TERNA
AOE: 1. Topical Therapy Otolaryngology
AOE: 2. Pain Assessment Otolaryngology
AOE: 3. Systemic Antimicrobial Therapy - Avoidance of Inappropriate Use Otolaryngology
PEDIATRICS ASTHMA CARE
There are no rules made for this category
GASTROENTEROLOGY
GASTROESOPHAGEAL REFLU- DISEASE
PQRI 60. Assess alarm symptoms in a patient with gastro esophageal reflu- disease (GERD) (Measure 60) Custom Rules Catalog/Quality Measures
PQRI 61A. Melena in a patient with gastro esophageal reflu- disease (GERD) (Measure 61) Custom Rules Catalog/Quality Measures
PQRI 61B. Hematemesis in a patient with gastro esophageal reflu- disease (Measure 61) Custom Rules Catalog/Quality Measures
PQRI 61C. Dysphagia in a patient with gastro esophageal reflu- disease (Measure 61) Custom Rules Catalog/Quality Measures
PQRI 61D. Persistent vomiting in a patient with gastro esophageal reflu- disease (GERD) (Measure 61) Custom Rules Catalog/Quality Measures
PQRI 61E. Anemia in a patient with gastro esophageal reflu- disease (Measure 61) Custom Rules Catalog/Quality Measures
PQRI 61F. Involuntary weight loss in a patient with gastro esophageal reflu- disease (Measure 61) Custom Rules Catalog/Quality Measures
PQRI 62. Perform biopsy for Barrett's esophagus in a patient with GERD (Measure 62) Custom Rules Catalog/Quality Measures
PQRI 63. Barium swallow in a patient with GERD (Measure 63) Custom Rules Catalog/Quality Measures
HEPATIC DISEASES / HEPATITIS
A third version of the anti-HCV screening test (EIA-3) Revised Rules Catalogue/Cirrhosis
AASLD guidelines for persons for whom therapy should be individualized Revised Rules Catalogue/Cirrhosis
AASLD guidelines for persons in whom therapy is contraindicated Revised Rules Catalogue/Cirrhosis
AASLD guidelines for persons in whom therapy is widely accepted Revised Rules Catalogue/Cirrhosis
Alcoholic cirrhosis Revised Rules Catalogue/Cirrhosis
American Association for the Study of Liver Diseases guidelines for testing persons for anti-HCV Revised Rules Catalogue/Cirrhosis
Clinical importance of HBV DNA Revised Rules Catalogue/Cirrhosis
Clinical importance of HbeAg Revised Rules Catalogue/Cirrhosis
Clinical importance of qualitative and quantitative PCR in diagnosis of HBV infection Revised Rules Catalogue/Cirrhosis
Clinical pointers of alcoholic liver disease Revised Rules Catalogue/Cirrhosis
Co-e-istence of HbsAg and anti-HBs as an indicator of carrier state Revised Rules Catalogue/Cirrhosis
Co-e-isting clinical conditions in patients with alcoholic liver disease Revised Rules Catalogue/Cirrhosis
Diagnosis of recurrence of hepatitis C following liver transplant Revised Rules Catalogue/Cirrhosis
Diagnostic approach to patient suffering from HCV related chronic liver disease Revised Rules Catalogue/Cirrhosis
Donor age as a predictor of outcome in liver transplant patient Revised Rules Catalogue/Cirrhosis
Effect of HCV genotype on survival after renal transplantation * Revised Rules Catalogue/Cirrhosis
Effect of pretransplantation anti-HCV status on posttransplantation clinical outcome * Revised Rules Catalogue/Cirrhosis
E-trahepatic manifestations of hepatitis C virus Revised Rules Catalogue/Cirrhosis
Factors affecting course of Hepatitis C Revised Rules Catalogue/Cirrhosis
Gentamicin - Subtherapeutic serum levels (Peak) - Life-threatening infections Revised Rules Catalogue/Cirrhosis
Harmful effects of interferon treatment in patients of renal transplantation* Revised Rules Catalogue/Cirrhosis
Hepatitis B surface antigen Revised Rules Catalogue/Cirrhosis
Hepatitis C virus related liver disease introduction Revised Rules Catalogue/Cirrhosis
In cirrhotic patients without underlying cause non-alcoholic fatty liver should be looked for by ultrasound abdomen. Revised Rules Catalogue/Cirrhosis
Investigations in chronic liver disease due to HCV Revised Rules Catalogue/Cirrhosis
Isolated detection of anti-HBc Revised Rules Catalogue/Cirrhosis
NIH guideline for coinfection with HIV in patients with HCV related liver disease Revised Rules Catalogue/Cirrhosis
Natural course of HCV related liver disease Revised Rules Catalogue/Cirrhosis
Natural history of hepatitis C Revised Rules Catalogue/Cirrhosis
Patterns of disease recurrence following liver transplantation* Revised Rules Catalogue/Cirrhosis
Perform ALT, AST and abdominal ultrasound in patients suffering from ascites Revised Rules Catalogue/Cirrhosis
Perform viral markers in pateints suffering from ascites Revised Rules Catalogue/Cirrhosis
Policy of testing all cadaver organ donors for anti-HCV* Revised Rules Catalogue/Cirrhosis
Precautions for interferon therapy Revised Rules Catalogue/Cirrhosis
Precautions to avoid HCV transmission during hemodialysis Revised Rules Catalogue/Cirrhosis
Rapid progression of HCV related liver disease in renal transplant patients. Revised Rules Catalogue/Cirrhosis
Rapid virologic response in Hepatitis C treatment Revised Rules Catalogue/Cirrhosis
Recommendation for interferon treatment in HCV positive patients prior to renal transplant Revised Rules Catalogue/Cirrhosis
Recommendation for monitoring of all HBV patients Revised Rules Catalogue/Cirrhosis
Recommendation for paracetamol dose in chronic liver disease due to HCV Revised Rules Catalogue/Cirrhosis
Recommendation for vaccination in chronic liver disease due to HCV Revised Rules Catalogue/Cirrhosis
Retreatment of patients who failed to achieve sustained virologic response (SVR) Revised Rules Catalogue/Cirrhosis
Risk factors for HCV transmission Revised Rules Catalogue/Cirrhosis
Risk of transmission of HCV to breastfed infants Revised Rules Catalogue/Cirrhosis
Risk of transmission of HCV to household contacts* Revised Rules Catalogue/Cirrhosis
Role of Alpha 1-antitrypsin deficiency in chronic liver disease Revised Rules Catalogue/Cirrhosis
Role of HCV genotyping Revised Rules Catalogue/Cirrhosis
Role of HCV in causing cirrhosis and as an indication of liver transplantation* Revised Rules Catalogue/Cirrhosis
Role of PCR in detecting HCV RNA Revised Rules Catalogue/Cirrhosis
Role of Recombinant immunoblot assay RIBA-2 in diagnosis of hepatitis C* Revised Rules Catalogue/Cirrhosis
Role of ceruloplasmin in diagnosis of Wilson's disease Revised Rules Catalogue/Cirrhosis
Role of liver in processing alcohol Revised Rules Catalogue/Cirrhosis
Role of ultrasound in cirrhosis Revised Rules Catalogue/Cirrhosis
Safe level of drinking to avoid alcohol related liver injury Revised Rules Catalogue/Cirrhosis
Survival analysis follwing transplant of HCV positive donor liver to HCV positive recepient * Revised Rules Catalogue/Cirrhosis
Symptoms of hepatitis C virus infection Revised Rules Catalogue/Cirrhosis
Symptoms of hepatitis C virus related cirrhosis of liver Revised Rules Catalogue/Cirrhosis
Test required to declare acute HBV hepatitis* Revised Rules Catalogue/Cirrhosis
The clinical course following liver transplantation for HCV infection Revised Rules Catalogue/Cirrhosis
The clinical importance of HBeAg Revised Rules Catalogue/Cirrhosis
The natural course of chronic hepatitis C Revised Rules Catalogue/Cirrhosis
Transmission of hepatitis C virus from mothers to infants Revised Rules Catalogue/Cirrhosis
Treatment decision for Hepatitis C patients having normal ALT and belong to low risk group.* Revised Rules Catalogue/Cirrhosis
Treatment of HCV recurrence following liver transplantation Revised Rules Catalogue/Cirrhosis
Treatment of alcohol induced liver disease Revised Rules Catalogue/Cirrhosis
Types of alcoholic liver disease Revised Rules Catalogue/Cirrhosis
Viral hepatitis due to Hepatitis C virus Revised Rules Catalogue/Cirrhosis
anti HCV testing in patients suffering from chronic liver disease Revised Rules Catalogue/Cirrhosis
Adefovir as a treatment of chronic hepatitis B Patient ED/Hepatitis
Alcohol Withdrawl in treatment of alcoholic hepatitis Patient ED/Hepatitis
Alcohol cessation in autoimmune hepatitis Patient ED/Hepatitis
Anti HBs if only marker detected point towards previous vaccination Patient ED/Hepatitis
Anti HCV in chronic hepatitis C Patient ED/Hepatitis
Antio-idants in treatment of alcoholic hepatitis Patient ED/Hepatitis
Autoantibodies in autoimmune hepatitis Patient ED/Hepatitis
Blood and organ donation can spread hepatitis C Patient ED/Hepatitis
Blood donation can spread hepatitis B Patient ED/Hepatitis
Breast feeding in a patient with hepatitis B Patient ED/Hepatitis
CBC in autoimmune hepatitis Patient ED/Hepatitis
Causes of acute hepatitis Patient ED/Hepatitis
Causes of autoimmune hepatitis Patient ED/Hepatitis
Causes of chronic hepatitis Patient ED/Hepatitis
Causes of developing alcoholic hepatitis Patient ED/Hepatitis
Clinical features of alcoholic hepatitis Patient ED/Hepatitis
Clinical features of hepatitis D infection Patient ED/Hepatitis
Complications of alcoholic liver disease Patient ED/Hepatitis
Definition of Hepatitis Patient ED/Hepatitis
Definition of Jaundice Patient ED/Hepatitis
Duration of treatment in patient with Hepatitis C Patient ED/Hepatitis
Education about interferon therapy Patient ED/Hepatitis
Entecavir as a treatment of chronic hepatitis B Patient ED/Hepatitis
E-trahepatic manifestations of hepatitis B Patient ED/Hepatitis
Fatigue may a manifestation of liver disease in hepatitis C Patient ED/Hepatitis
Follow up of acute hepatitis B Patient ED/Hepatitis